Urokinase receptor cleavage: A crucial step in 14 fibroblast-to-myofibroblast differentiation

被引:77
作者
Bernstein, Audrey M. [1 ]
Twining, Sally S.
Warejcka, Debra J.
Tall, Edward
Masur, Sandra K.
机构
[1] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA
[3] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA
关键词
D O I
10.1091/mbc.E06-10-0912
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Fibroblasts migrate into and repopulate connective tissue wounds. At the wound edge, fibroblasts differentiate into myofibroblasts, and they promote wound closure. Regulated fibroblast-to-myofibroblast differentiation is critical for regenerative healing. Previous studies have focused on the role in fibroblasts of urokinase plasmingen activator/urokinase plasmingen activator receptor (uPA/uPAR), an extracellular protease system that promotes matrix remodeling, growth factor activation, and cell migration. Whereas fibroblasts have substantial uPA activity and uPAR expression, we discovered that cultured myofibroblasts eventually lost cell surface uPA/uPAR. This led us to investigate the relevance of uPA/uPAR activity to myofibroblast differentiation. We found that fibroblasts expressed increased amounts of full-length cell surface uPAR (D1D2D3) compared with myofibroblasts, which had reduced expression of D1D2D3 but increased expression of the truncated form of uPAR (D2D3) on their cell surface. Retaining full-length uPAR was found to be essential for regulating myofibroblast differentiation, because 1) protease inhibitors that prevented uPAR cleavage also prevented myofibroblast differentiation, and 2) overexpression of cDNA for a noncleavable form of uPAR inhibited myofibroblast differentiation. These data support a novel hypothesis that maintaining full-length uPAR on the cell surface regulates the fibroblast to myofibroblast transition and that down-regulation of uPAR is necessary for myofibroblast differentiation.
引用
收藏
页码:2716 / 2727
页数:12
相关论文
共 59 条
[1]   AN ASSAY FOR TRANSFORMING GROWTH-FACTOR-BETA USING CELLS TRANSFECTED WITH A PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTER LUCIFERASE CONSTRUCT [J].
ABE, M ;
HARPEL, JG ;
METZ, CN ;
NUNES, I ;
LOSKUTOFF, DJ ;
RIFKIN, DB .
ANALYTICAL BIOCHEMISTRY, 1994, 216 (02) :276-284
[2]   OCCUPANCY OF THE CANCER CELL UROKINASE RECEPTOR (UPAR) - EFFECTS OF ACID ELUTION AND EXOGENOUS UPA ON CELL-SURFACE UROKINASE (UPA) [J].
BAKER, MS ;
LIANG, XM ;
DOE, WF .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1117 (02) :143-152
[3]   Proteolytic regulation of the urokinase receptor/CD87 on monocytic cells by neutrophil elastase and cathepsin G [J].
Beaufort, N ;
Leduc, D ;
Rousselle, JC ;
Magdolen, V ;
Luther, T ;
Namane, A ;
Chignard, M ;
Pidard, D .
JOURNAL OF IMMUNOLOGY, 2004, 172 (01) :540-549
[4]  
BEHRENDT N, 1991, J BIOL CHEM, V266, P7842
[5]   Urokinase anchors uPAR to the actin cytoskeleton [J].
Bernstein, AM ;
Greenberg, RS ;
Taliana, L ;
Masur, SK .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (09) :2967-2977
[6]   uPAR: A versatile signalling orchestrator [J].
Blasi, F ;
Carmeliet, P .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (12) :932-943
[7]   Differential regulation of key stages in early corneal wound healing by TGF-β Isoforms and their inhibitors [J].
Carrington, Louise M. ;
Albon, Julie ;
Anderson, Ian ;
Kamma, Christina ;
Boulton, Mike .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (05) :1886-1894
[8]   Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins [J].
Czekay, RP ;
Aertgeerts, K ;
Curriden, SA ;
Loskutoff, DJ .
JOURNAL OF CELL BIOLOGY, 2003, 160 (05) :781-791
[9]   Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity [J].
Czekay, RP ;
Kuemmel, TA ;
Orlando, RA ;
Farquhar, MG .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (05) :1467-1479
[10]   Urokinase/urokinase receptor and vitronectin/αvβ3 integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways [J].
Degryse, B ;
Orlando, S ;
Resnati, M ;
Rabbani, SA ;
Blasi, F .
ONCOGENE, 2001, 20 (16) :2032-2043